Afimkibart trials for Moderately to Severely Active Crohns Disease

All Afimkibart trials · All Moderately to Severely Active Crohns Disease trials

Phase breakdown

Recruiting trials studying Afimkibart for Moderately to Severely Active Crohns Disease

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
  NCT06819891 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · 199 locations
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
  NCT06819878 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · 374 locations
• A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
  NCT07298421 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 14 locations

Common questions

How many trials study Afimkibart for Moderately to Severely Active Crohns Disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.